Founded in 2021 and launched last month, this health-tech wants to support asthma and COPD patients with data-driven diagnosis and treatment. Our latest Start-up of the Week hopes to provide aid to those with uncontrolled asthma or COPD. Phyxiom is an Irish health-tech that wants to improve diagnosis accuracy and treatment outcomes for people with asthma and COPD using its AI-driven data platform. “At our core is our clinical team and our AI platform that, combined, support clinicians with evidence-based data for their diagnosis and treatment decisions,” says CEO Grace O’Donnell. “Our goal is to be the dominant respiratory physician platform in the market globally,” says O’Donnell.